• Je něco špatně v tomto záznamu ?

Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ Sites

D. Holub, P. Flodrova, T. Pika, P. Flodr, M. Hajduch, P. Dzubak,

. 2019 ; 2019 (-) : 3689091. [pub] 20190131

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19027754

Grantová podpora
NV16-31156A MZ0 CEP - Centrální evidence projektů

We have determined patient's amyloid subtype through immunohistochemical and proteomic analyses of formalin-fixed, paraffin-embedded (FFPE) tissue samples from two affected organs per patient. Amyloid typing, via immunohistochemistry (IHC) and laser microdissection followed by the combination of liquid chromatography with mass spectrometry (LMD-LC-MS), was performed using tissue samples of the human heart, liver, kidney, tongue, and small intestine from 11 patients, and the results were compared with clinical data. LMD-LC-MS correctly typed AL amyloidosis in all 22 FFPE tissue samples despite tissue origin. In contrast, IHC was successful only in the analysis of eight FFPE tissue samples with differences between the examined organs. In the majority of LMD-LC-MS typed samples, the level of IHC staining intensity for transthyretin and serum amyloid A was the same as that for Ig κ and Ig λ antibodies, suggesting low Ig κ or Ig λ antibodies reactivity and the additional antibody clones were essential for correct typing. Both methods used in the study were found to be suitable for amyloid typing, although LMD-LC-MS yielded more promising results than IHC.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027754
003      
CZ-PrNML
005      
20200616091801.0
007      
ta
008      
190813s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2019/3689091 $2 doi
035    __
$a (PubMed)30834260
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Holub, Dusan $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00 Olomouc, Czech Republic.
245    10
$a Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ Sites / $c D. Holub, P. Flodrova, T. Pika, P. Flodr, M. Hajduch, P. Dzubak,
520    9_
$a We have determined patient's amyloid subtype through immunohistochemical and proteomic analyses of formalin-fixed, paraffin-embedded (FFPE) tissue samples from two affected organs per patient. Amyloid typing, via immunohistochemistry (IHC) and laser microdissection followed by the combination of liquid chromatography with mass spectrometry (LMD-LC-MS), was performed using tissue samples of the human heart, liver, kidney, tongue, and small intestine from 11 patients, and the results were compared with clinical data. LMD-LC-MS correctly typed AL amyloidosis in all 22 FFPE tissue samples despite tissue origin. In contrast, IHC was successful only in the analysis of eight FFPE tissue samples with differences between the examined organs. In the majority of LMD-LC-MS typed samples, the level of IHC staining intensity for transthyretin and serum amyloid A was the same as that for Ig κ and Ig λ antibodies, suggesting low Ig κ or Ig λ antibodies reactivity and the additional antibody clones were essential for correct typing. Both methods used in the study were found to be suitable for amyloid typing, although LMD-LC-MS yielded more promising results than IHC.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a amyloid $x genetika $x izolace a purifikace $x metabolismus $7 D000682
650    _2
$a amyloidóza $x genetika $x metabolismus $x patologie $7 D000686
650    _2
$a protilátky $x imunologie $7 D000906
650    _2
$a chromatografie kapalinová $7 D002853
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a formaldehyd $7 D005557
650    _2
$a lidé $7 D006801
650    _2
$a tenké střevo $x metabolismus $x patologie $7 D007421
650    _2
$a ledviny $x metabolismus $x patologie $7 D007668
650    _2
$a játra $x metabolismus $x patologie $7 D008099
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a hmotnostní spektrometrie $7 D013058
650    _2
$a lidé středního věku $7 D008875
650    _2
$a myokard $x metabolismus $x patologie $7 D009206
650    _2
$a zalévání tkání do parafínu $7 D016612
650    12
$a proteomika $7 D040901
650    _2
$a tkáňová distribuce $x genetika $7 D014018
650    _2
$a jazyk $x metabolismus $x patologie $7 D014059
655    _2
$a časopisecké články $7 D016428
700    1_
$a Flodrová, Pavla, $d 1984- $7 xx0139492 $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 779 00 Olomouc, Czech Republic.
700    1_
$a Pika, Tomas $u Department of Hemato-Oncology, University Hospital Olomouc, I.P. Pavlova 185/6, 779 00 Olomouc, Czech Republic.
700    1_
$a Flodr, Patrik $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 779 00 Olomouc, Czech Republic.
700    1_
$a Hajduch, Marian $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00 Olomouc, Czech Republic. Cancer Research Czech Republic, Hnevotinska 5, 779 00 Olomouc, Czech Republic.
700    1_
$a Dzubak, Petr $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00 Olomouc, Czech Republic. Cancer Research Czech Republic, Hnevotinska 5, 779 00 Olomouc, Czech Republic.
773    0_
$w MED00182164 $t BioMed research international $x 2314-6141 $g Roč. 2019, č. - (2019), s. 3689091
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30834260 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20200616091758 $b ABA008
999    __
$a ok $b bmc $g 1432903 $s 1066214
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 2019 $c - $d 3689091 $e 20190131 $i 2314-6141 $m BioMed research international $n Biomed Res Int $x MED00182164
GRA    __
$a NV16-31156A $p MZ0
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Možnosti archivace